Legal status by country
Is Azelaprag legal?
Written by Aaron CuhaReviewed Sep 2026
How Azelaprag is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational; development halted | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | Phase 2 terminated in February 2025 for liver transaminitis. No approval and no active registered trial. | No trial registered in the UK. | No trial registered in Australia. | No trial registered in Canada. |
US FDA status: Not approved. Investigational only. The phase 2 combination trial with tirzepatide was terminated for liver transaminitis and no further azelaprag trial is registered.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.